GKB

GKB Ophthalmics Share Price

₹99.00 -0.98 (-0.98%)

23 Dec, 2024 06:49

SIP TrendupStart SIP in GKB

Start SIP

Performance

  • Low
  • ₹0
  • High
  • ₹0
  • 52 Week Low
  • ₹0
  • 52 Week High
  • ₹0
  • Open Price₹0
  • Previous Close₹0
  • Volume

Investment Returns

  • Over 1 Month + 2.43%
  • Over 3 Month -10.73%
  • Over 6 Month -1.43%
  • Over 1 Year -2.65%
SIP Lightning

Smart Investing Starts Here Start SIP with GKB Ophthalmics for Steady Growth!

Invest Now

GKB Ophthalmics Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • -13.7
  • PEG Ratio
  • 12.2
  • Market Cap Cr
  • 50
  • P/B Ratio
  • 0.8
  • Average True Range
  • 4.87
  • EPS
  • -
  • Dividend Yield
  • 0
  • MACD Signal
  • -0.51
  • RSI
  • 47.03
  • MFI
  • 74.84

GKB Ophthalmics Financials

GKB Ophthalmics Technicals

EMA & SMA

Current Price
₹99.00
-0.98 (-0.98%)
  • stock-down_img
  • Bullish Moving Average 0
  • stock-up_img
  • Bearish Moving Average 0
  • 20 Day
  • ₹100.31
  • 50 Day
  • ₹102.05
  • 100 Day
  • ₹103.66
  • 200 Day
  • ₹103.39

Resistance and Support

100.51 Pivot Speed
  • R3 106.02
  • R2 104.51
  • R1 102.02
  • S1 98.02
  • S2 96.51
  • S3 94.02

What's your outlook on GKB Ophthalmics?

You can only vote for once

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Gkb Ophthalmics has an operating revenue of Rs. 97.76 Cr. on a trailing 12-month basis. An annual revenue growth of 17% is outstanding, Pre-tax margin of -3% needs improvement, ROE of -4% is poor and needs improvement. The company has a reasonable debt to equity of 2%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 12 which is a POOR score indicating inconsistency in earnings, a RS Rating of 31 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B- which is evident from recent demand for the stock, Group Rank of 36 indicates it belongs to a strong industry group of Medical-Products and a Master Score of D is close to being the worst. Institutional holding has remained stable in the last reported quarter. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

GKB Ophthalmics Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2024-11-14 Quarterly Results
2024-08-13 Quarterly Results
2024-05-30 Audited Results
2024-02-14 Quarterly Results
2023-11-14 Quarterly Results

GKB Ophthalmics F&O

GKB Ophthalmics Shareholding Pattern

50.95%
1.79%
36.34%
10.92%

About GKB Ophthalmics

  • NSE Symbol
  • GKB
  • BSE Symbol
  • 533212
  • Chairman & Managing Director
  • Mr. K G Gupta
  • ISIN
  • INE265D01015

Similar Stocks to GKB Ophthalmics

GKB Ophthalmics FAQs

GKB Ophthalmics share price is ₹99 As on 23 December, 2024 | 06:35

The Market Cap of GKB Ophthalmics is ₹49.9 Cr As on 23 December, 2024 | 06:35

The P/E ratio of GKB Ophthalmics is -13.7 As on 23 December, 2024 | 06:35

The PB ratio of GKB Ophthalmics is 0.8 As on 23 December, 2024 | 06:35

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23